• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Edwards Lifesciences Corporation

    5/30/25 4:27:10 PM ET
    $EW
    Industrial Specialties
    Health Care
    Get the next $EW alert in real time by email
    SD 1 formsd_cmrmay2025.htm SD Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    Form SD
     
     
    SPECIALIZED DISCLOSURE REPORT
    EDWARDS LIFESCIENCES CORPORATION
    (Exact Name of Registrant as Specified in Charter)
     
    Delaware1-1552536-4316614
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File No.)
    (IRS Employer
    Identification No.)
     
    One Edwards Way, Irvine, California92614
    (Address of Principal Executive Offices)(Zip Code)
    Scott B. Ullem (949) 250-2500
    (Name and telephone number, including area code,
    of the person to contact in connection with this report.)
    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:
     
    ☒Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
     
    ☐Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended .
     
     
     
                                            


    Section 1—Conflict Minerals Disclosure
    Item 1.01—Conflict Minerals Disclosure and Report
    A copy of the conflict minerals report is publicly available on Edwards’ website at www.edwards.com under “About Us—Corporate Compliance—Responsible Supply Chain—Supplier Resources” or at https://www.edwards.com/about-us/responsible-supply-chain.
    Item 1.02—Exhibit
    A copy of the conflict minerals report is attached hereto as Exhibit 1.01 and incorporated herein by this reference.
    Section 2—Resource Extraction Issuer Disclosure
    Item 2.01—Resource Extraction Issuer Disclosure and Report
    Not applicable.
    Section 3—Exhibits
    Item 3.01—Exhibits
    Exhibit No. Description
    1.01 
    Conflict Minerals Report as contemplated by Item 1.02 of this Form.


    1



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
     
      
    EDWARDS LIFESCIENCES CORPORATION
    May 30, 2025
      By: /s/ SCOTT B. ULLEM
       Scott B. Ullem
       Corporate Vice President, Chief Financial Officer


    2



    EXHIBIT INDEX
     
    Exhibit Number Description
    1.01 Conflict Minerals Report as contemplated by Item 1.02 of this Form.



    3

    Get the next $EW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EW

    DatePrice TargetRatingAnalyst
    4/24/2025$80.00Neutral → Overweight
    Piper Sandler
    1/30/2025$75.00 → $90.00Hold → Buy
    Stifel
    1/16/2025$60.00Peer Perform → Underperform
    Wolfe Research
    12/16/2024Neutral → Buy
    BofA Securities
    10/11/2024$70.00Equal-Weight
    Morgan Stanley
    9/18/2024$85.00 → $70.00Buy → Hold
    Jefferies
    7/31/2024Neutral → Outperform
    Daiwa Securities
    7/29/2024Underperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $EW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Global President TAVR & Surg Wood Larry L exercised 8,950 shares at a strike of $59.26 and sold $673,268 worth of shares (8,950 units at $75.23) (SEC Form 4)

      4 - Edwards Lifesciences Corp (0001099800) (Issuer)

      6/16/25 5:09:27 PM ET
      $EW
      Industrial Specialties
      Health Care
    • CEO Zovighian Bernard J sold $1,317,837 worth of shares (17,066 units at $77.22) (SEC Form 4)

      4 - Edwards Lifesciences Corp (0001099800) (Issuer)

      6/3/25 5:15:54 PM ET
      $EW
      Industrial Specialties
      Health Care
    • CVP,Strategy/Corp Development Bobo Donald E Jr sold $198,911 worth of shares (2,570 units at $77.40), decreasing direct ownership by 5% to 50,356 units (SEC Form 4)

      4 - Edwards Lifesciences Corp (0001099800) (Issuer)

      6/2/25 5:01:58 PM ET
      $EW
      Industrial Specialties
      Health Care

    $EW
    SEC Filings

    See more
    • SEC Form 11-K filed by Edwards Lifesciences Corporation

      11-K - Edwards Lifesciences Corp (0001099800) (Filer)

      6/17/25 4:29:24 PM ET
      $EW
      Industrial Specialties
      Health Care
    • SEC Form 11-K filed by Edwards Lifesciences Corporation

      11-K - Edwards Lifesciences Corp (0001099800) (Filer)

      6/17/25 4:28:40 PM ET
      $EW
      Industrial Specialties
      Health Care
    • SEC Form SD filed by Edwards Lifesciences Corporation

      SD - Edwards Lifesciences Corp (0001099800) (Filer)

      5/30/25 4:27:10 PM ET
      $EW
      Industrial Specialties
      Health Care

    $EW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East

      NEW YORK, June 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on June 24th Equities are rising Tuesday morning as traders closely monitor the latest developments in the Middle East. On Monday, the major averages rose by close to 1% amid the region's ongoing conflict.At approximately 6 PM ET yesterday evening, President Donald Trump announced on Truth Social that a ceasefire agreement has been reached between Israel and Iran. However, Israel and Iran l

      6/24/25 8:55:00 AM ET
      $EW
      $ICE
      Industrial Specialties
      Health Care
      Investment Bankers/Brokers/Service
      Finance
    • Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

      Edwards Lifesciences (NYSE:EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease. The results of a new real-world study of more than 24,000 patients demonstrated that intervening on the disease before symptoms develop reduces the economic and resource burden on the healthcare system and improves patient outcomes. Prompt intervention for severe AS patients before symptoms developed resulted in: Significantly lower costs for the healthcare system at 1 year ($36,000 less per patient); Shorter length of stay during their treatm

      5/22/25 2:30:00 AM ET
      $EW
      Industrial Specialties
      Health Care
    • Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

      Edwards Lifesciences (NYSE:EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, will participate in a fireside chat at 10:40 a.m. Pacific Time. A live webcast of the discussion will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com, with an archived version accessible later the same day. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and p

      5/6/25 7:05:00 AM ET
      $EW
      Industrial Specialties
      Health Care